We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-2.07%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$19.3B
AUM Growth
-$803M
Cap. Flow
+$159M
Cap. Flow %
0.82%
Top 10 Hldgs %
30.79%
Holding
732
New
52
Increased
325
Reduced
233
Closed
41

Top Buys

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$78.3M
2
NEE icon
NextEra Energy
NEE
+$57M
3
NVDA icon
NVIDIA
NVDA
+$48M
4
BABA icon
Alibaba
BABA
+$43.4M
5
AAPL icon
Apple
AAPL
+$39M

Top Sells

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$87.5M
2
RVMD icon
Revolution Medicines
RVMD
+$45.5M
3
ABT icon
Abbott
ABT
+$44.5M
4
JPM icon
JPMorgan Chase
JPM
+$44.3M
5
IQV icon
IQVIA
IQV
+$43M

Sector Composition

Rank Sector Weight
1 Technology 32.73%
2 Healthcare 27.11%
3 Financials 9.44%
4 Consumer Discretionary 7.72%
5 Communication Services 7.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
1
NVIDIA
NVDA
$4.92T
$1.22B 6.36%
7,023,574
+261,537
+4% +$48M
MSFT icon
2
Microsoft
MSFT
$2.99T
$991M 5.15%
2,678,207
+88,757
+3% +$37.1M
AAPL icon
3
Apple
AAPL
$4.8T
$889M 4.62%
3,503,348
+149,720
+4% +$39M
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.3T
$743M 3.86%
2,582,917
+60,637
+2% +$19.1M
AMZN icon
5
Amazon
AMZN
$2.69T
$528M 2.74%
2,535,587
+30,379
+1% +$6.69M
AVGO icon
6
Broadcom
AVGO
$1.8T
$439M 2.28%
1,418,532
-14,837
-1% -$4.88M
LLY icon
7
Eli Lilly
LLY
$1.02T
$384M 1.99%
417,282
-28,982
-6% -$29.4M
ABBV icon
8
AbbVie
ABBV
$448B
$249M 1.29%
1,144,668
+67,035
+6% +$14.9M
GOOG icon
9
Alphabet (Google) Class C
GOOG
$4.29T
$246M 1.28%
859,128
+54,474
+7% +$17.1M
GILD icon
10
Gilead Sciences
GILD
$165B
$233M 1.21%
1,670,288
-161,897
-9% -$22.7M
TSM icon
11
TSMC
TSM
$2.09T
$222M 1.15%
655,660
-108,141
-14% -$37.2M
MCK icon
12
McKesson
MCK
$97.3B
$207M 1.08%
239,664
+34,370
+17% +$30.7M
JNJ icon
13
Johnson & Johnson
JNJ
$599B
$195M 1.01%
798,815
+49,216
+7% +$11.5M
MA icon
14
Mastercard
MA
$484B
$195M 1.01%
389,267
-27,807
-7% -$14.6M
PANW icon
15
Palo Alto Networks
PANW
$284B
$192M 1%
1,198,697
+125,478
+12% +$21.1M
LRCX icon
16
Lam Research
LRCX
$384B
$185M 0.96%
866,516
-175,995
-17% -$39.4M
V icon
17
Visa
V
$686B
$176M 0.92%
583,683
-32,892
-5% -$10.6M
TMO icon
18
Thermo Fisher Scientific
TMO
$196B
$174M 0.9%
354,087
+56,368
+19% +$30.6M
MU icon
19
Micron Technology
MU
$977B
$174M 0.9%
514,404
-14,436
-3% -$5.65M
NEE icon
20
NextEra Energy
NEE
$184B
$170M 0.88%
1,826,628
+640,824
+54% +$57M
META icon
21
Meta Platforms (Facebook)
META
$1.64T
$161M 0.84%
281,020
+31,101
+12% +$19.9M
MRK icon
22
Merck
MRK
$307B
$159M 0.83%
1,322,654
+46,967
+4% +$5.42M
ISRG icon
23
Intuitive Surgical
ISRG
$125B
$151M 0.79%
328,149
+37,107
+13% +$18.8M
REGN icon
24
Regeneron Pharmaceuticals
REGN
$70.5B
$144M 0.75%
186,388
-18,944
-9% -$14.5M
JPM icon
25
JPMorgan Chase
JPM
$901B
$140M 0.73%
476,801
-145,890
-23% -$44.3M

Similar funds

Candriam SCA's Q1 2026 Portfolio in Review

As of Q1 2026, Candriam SCA held 732 positions worth $19.3B, down 4% from $20.1B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Candriam SCA's Q1 2026 filing shows 52 new, 325 increased, 233 reduced and 41 closed positions. Its largest new stake was Service Corp International: 360,195 shares worth $29.7M. The largest sale was Nu Holdings, an estimated $87.5M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2026 buy was Service Corp International: 360,195 shares worth $29.7M.
  • Candriam SCA added most to KLA in Q1 2026, an estimated $78.3M increase.
  • Candriam SCA's biggest Q1 2026 reduction was Nu Holdings, cutting an estimated $87.5M.
  • Candriam SCA fully exited Banco Macro in Q1 2026, selling an estimated $25.6M.
  • Candriam SCA's ten largest holdings make up 31% of its $19.3B portfolio in Q1 2026.
  • Candriam SCA opened 52 new positions and closed 41 in Q1 2026.
  • Candriam SCA's portfolio value fell 4% quarter-over-quarter to $19.3B.

Based on Candriam SCA's 13F filing for Q1 2026, filed 30 Apr 2026.